I can agree with you on the vaccine, even though the vaccine is a lot less effective if you have already been sexually active I think it should be offered to all (and I could even include males in that).
But right now it's new and therefore expensive.
If the patent had already ended, things would have been different.
I cannot agree with you on the screening issue though.
PAP screening, although very successful at reducing cervical cancer death rates are not perfect.
And they're worse in young people.
There are two reasons for this.
Cervical cancer is very rare between the ages of 20-25.
Abnormal cells are very common, but often self limiting.
This means that you end up treating lots of things which will never cause problems while not improving the odds of survival.
Which is what the best evidence available, such as this, indicates.
I'm using this paper as an example as it's open source but just in case you're not comfy with the format, I'll summarise the key data below.
No evidence that screening women aged 22-24 reduced the incidence of cervical cancer at ages 25-29.
Screening was associated with a 60% reduction of cancers in women aged 40.
This increases to 80% at age 64.
Screening was particularly effective in preventing advanced stage cancers.
If you look at the young women who did get cancer then you'll see that almost all of them had PAP smears done which detected cancer at an early stage.
Because they had symptoms.
The numbers don't add up for PAP screening to be started any younger and it's probably England that are correct with the age at 25 rather than the rest of the UK with the age of 20.
Does that make sense?